Why the study?
Does an N-terminal-shortened cardiac MyBP-C mutation alter contractile properties in a mouse model of familial hypertrophic cardiomyopathy?
Population
Knock-in mouse model carrying N-terminal-shortened cardiac Myosin-binding protein-C (MyBP-C)
Comparison
N-terminal-shortened cardiac MyBP-C mutation vs Wild-type mice
Design
Preclinical
Authors
Loading...
May promote hypercontractility in familial HCM; leaves open human translation from this animal model.
Does an N-terminal-shortened cardiac MyBP-C mutation alter contractile properties in a mouse model of familial hypertrophic cardiomyopathy?
N-terminal mutations of cardiac MyBP-C may lead to a hypercontractile state by increasing calcium sensitivity of force development, providing insight into the pathophysiology of familial hypertrophic cardiomyopathy.
Witt et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: